Batenburg WW - Search Results

1

ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?

Danser AH, Batenburg WW, van den Meiracker AH, Danilov SM. Danser AH, et al. Among authors: batenburg ww. Pharmacol Ther. 2007 Mar;113(3):607-18. doi: 10.1016/j.pharmthera.2006.12.001. Epub 2006 Dec 28. Pharmacol Ther. 2007. PMID: 17257685 Review.

2

Bradykinin-induced relaxation of coronary microarteries: S-nitrosothiols as EDHF?

Batenburg WW, Popp R, Fleming I, de Vries R, Garrelds IM, Saxena PR, Danser AH. Batenburg WW, et al. Br J Pharmacol. 2004 May;142(1):125-35. doi: 10.1038/sj.bjp.0705747. Epub 2004 Apr 5. Br J Pharmacol. 2004. PMID: 15066907 Free PMC article.

3

Selective angiotensin-converting enzyme C-domain inhibition is sufficient to prevent angiotensin I-induced vasoconstriction.

van Esch JH, Tom B, Dive V, Batenburg WW, Georgiadis D, Yiotakis A, van Gool JM, de Bruijn RJ, de Vries R, Danser AH. van Esch JH, et al. Among authors: batenburg ww. Hypertension. 2005 Jan;45(1):120-5. doi: 10.1161/01.HYP.0000151323.93372.f5. Epub 2004 Dec 6. Hypertension. 2005. PMID: 15583077

4

Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s).

Batenburg WW, Tom B, Schuijt MP, Danser AH. Batenburg WW, et al. Vascul Pharmacol. 2005 Feb;42(3):109-18. doi: 10.1016/j.vph.2005.01.005. Vascul Pharmacol. 2005. PMID: 15792928 Review.

5

Prorenin anno 2008.

Danser AH, Batenburg WW, van Esch JH, Krop M. Danser AH, et al. Among authors: batenburg ww. J Mol Med (Berl). 2008 Jun;86(6):655-8. doi: 10.1007/s00109-008-0318-2. Epub 2008 Mar 6. J Mol Med (Berl). 2008. PMID: 18322669 Free PMC article. Review.

6

Corticosteroid-dependent, aldosterone-independent mineralocorticoid-receptor activation in the heart.

van den Meiracker AH, Batenburg WW. van den Meiracker AH, et al. Among authors: batenburg ww. J Hypertens. 2008 Jul;26(7):1307-9. doi: 10.1097/HJH.0b013e328305e195. J Hypertens. 2008. PMID: 18551003 No abstract available.

7

Diabetic complications: a role for the prorenin-(pro)renin receptor-TGF-beta1 axis?

van den Heuvel M, Batenburg WW, Danser AH. van den Heuvel M, et al. Among authors: batenburg ww. Mol Cell Endocrinol. 2009 Apr 29;302(2):213-8. doi: 10.1016/j.mce.2008.09.010. Epub 2008 Sep 17. Mol Cell Endocrinol. 2009. PMID: 18840499

8

Urinary renin, but not angiotensinogen or aldosterone, reflects the renal renin-angiotensin-aldosterone system activity and the efficacy of renin-angiotensin-aldosterone system blockade in the kidney.

van den Heuvel M, Batenburg WW, Jainandunsing S, Garrelds IM, van Gool JM, Feelders RA, van den Meiracker AH, Danser AH. van den Heuvel M, et al. Among authors: batenburg ww. J Hypertens. 2011 Nov;29(11):2147-55. doi: 10.1097/HJH.0b013e32834bbcbf. J Hypertens. 2011. PMID: 21941204

9

(Pro)renin and its receptors: pathophysiological implications.

Batenburg WW, Danser AH. Batenburg WW, et al. Clin Sci (Lond). 2012 Aug 1;123(3):121-33. doi: 10.1042/CS20120042. Clin Sci (Lond). 2012. PMID: 22494159 Review.

10

Long-lasting physiological antagonism of calcitonin gene-related peptide towards endothelin-1 in rat mesenteric arteries and human coronary arteries.

Labruijere S, Compeer MG, van den Bogaerdt AJ, van den Brink AM, De Mey JG, Danser AH, Batenburg WW. Labruijere S, et al. Among authors: batenburg ww. Eur J Pharmacol. 2013 Nov 15;720(1-3):303-9. doi: 10.1016/j.ejphar.2013.10.012. Epub 2013 Oct 18. Eur J Pharmacol. 2013. PMID: 24140435

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page